Abstract
Ideal premature ejaculation (PE) clinical trial (CT) design involves defining the population with the ISSM definition for PE, a cohort or case–control observational design, or a double-blind, placebo-controlled randomized CT design, and the use of sensitive, validated and reproducible outcome measures including stop-watched measured Intra-vaginal Ejaculatory Latency-Time and Patient Related Outcomes measured with the premature Ejaculation Profile, the Index of PE, and in drug CTs the Clinical Impression of Change. Partner Reported Outcome (PaROs) measures are also strongly recommended. This chapter reviews the methodology used in the first large CTs conducted in men with PE and the latest recommendations proposed for such CTs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McMahon CG, Waldinger M, Rowland D, Assalian P, Kim YC, Bechara A, Riley A (2006) Ejaculatory disorders. In: Porst H, Buvat J (eds) Standard practice in sexual medicine. Blackwell Publishing, Malden, pp 188–209
McMahon CG (2008) Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies—Part I—defining and selecting the study population. J Sex Med 5:1805–1816
McMahon CG (2008) Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies—Part II—study design, outcomes measures, data analysis, and reporting. J Sex Med 5:1817–1833
Porst H, Vardi Y, Akkus E, Melman A, Park NC, Seftel AD, Teloken C, Wyllie M (2010) Standards for clinical trials in male sexual dysfunctions. J Sex Med 7:414–444
Mulhall JP (2004) Understanding erectile dysfunction medication preference studies. Curr Opin Urol 14:367–373
McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJG, Incroccil L, Laan E, Meuleman E, Perelman MA, Rosen R, Rowland DL, Segraves R (2008) An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 5:1590–1606
Althof SE, Abdo CHN, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger MD, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJG, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Tan HM, International Society for Sexual Medicine (2010) International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 7:2947–2969
Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, Ekmekcioglu O, Kendirci M, Semerci B, Kadioglu A (2011) The comparison of premature ejaculation assessment questionnaires and their sensitivity for the four premature ejaculation syndromes: results from the Turkish society of andrology sexual health survey. J Sex Med 8:1177–1185
Pryor JL, Broderick GA, Ho KF, Jamieson C, Gagnon D (2005) Comparison of estimated versus measured intravaginal ejaculatory latency time (IELT) in men with and without premature ejaculation (PE) J Sex Med 3:54 (abstract 126)
Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD (2007) Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol 177:1059–1064
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M (2005) A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2:492–497
Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH (2008) Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacity. J Sex Med 5:492–499
Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman MJ, Jamieson C (2005) Premature ejaculation: an observational study of men and their partners. J Sex Med 2:58–367
Giuliano F, Patrick DL, Porst H, La Pera G, Kokoszaka A, Merchant S, Rothman M, Gagnon DD, Polverejan E (2008) Premature ejaculation: results from a five-country European observational study. Eur Urol 53:1048–1057
Patrick DL, Rowland D, Rothman M (2007) Interrelation-ship among measures of premature ejaculation: the central role of perceived control. J Sex Med 4:780–788
Rowland DL, Patrick DL, Rothman M, Gagnon DD (2007) The psychological burden of premature ejaculation. J Urol 177:1065–1070
Segraves R, Balon R, Clayton A (2007) Proposal for changes in diagnostic criteria for sexual dysfunctions. J Sex Med 4:567–580
Althof S, Rosen R, Symonds t, Mundayat R, May K, Abraham L (2006) Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med 3:465–475
Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNutly P, Rothman M (2009) The premature ejaculation profile: validation of self-reported outcome measures for research and practice. BJU int 103:358–364
Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, Bull S (2010) Validity of the patient-reported clinical global impression of change as a measure of treatment response in men with premature ejaculation. J Sex Med 7:2243–2252
Rowland DL, Strassberg DS, de Gouveia Brazao CA, Slob AK (2000) Ejaculatory latency and control in men with premature ejaculation: An analysis across sexual activities using multiple sources of information. J Psychosom Res 48:69–77
Carson C, Gunn K (2006) Premature ejaculation: definition and prevalence. Int J Impot Res 18:S5–S13
McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW, Tesfaye F, Rothman M, Rivas DA, Porst H (2011) Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med 8:524–539
Waldinger MD, Hengeveld MW, Zwinderman AH (1994) Paroxetine treatment of premature ejaculation: a double blind, randomized, placebo-controlled study. Am J Psychiatry 15:1377–1379
Haensel SM, Rowland DL, Kallan KT (1996) Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 156:1310–1315
Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F (2009) Dapoxetine in the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 55:957–968
Dinsmore WW, Hackett G, Goldmeier D (2007) Topical eutectic mixture for premature ejaculation. BJU Int 99:369–375
Dinsmore WW, Wyllie MG (2009) PSD 502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int 103:940–949
Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B (2004) Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16:369–381
Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA (2008) Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med 5:188–193
Safarinejad MR, Hosseini SY (2006) Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 26:27–31
De Carufel F, Trudel G (2006) Effects of a new functional-sexological treatment for premature ejaculation. J Sex Marital Ther 32:97–114
Abdel-Hamid IA, El Naggar EA, El Gilany AH (2001) Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 13:41–45
Wang WF, Wang Y, Minhas S, Ralph D (2007) Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol 14:331–335
Sunay D, Sunay M, Aydoğmuş Y, Bağbancı S, Arslan H, Karabulut A, Emir L (2011) Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol 59:765–771
Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH (2007) The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men. J Sex Med 4:1028–1037
Carson C, Wylie M (2010) Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. J Sex Med 7:3179–3189
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Buvat, J. (2013). Clinical Trial Designs for Premature Ejaculation: Observational, Intervention and Intervention Preference Studies. In: Jannini, E., McMahon, C., Waldinger, M. (eds) Premature Ejaculation. Springer, Milano. https://doi.org/10.1007/978-88-470-2646-9_26
Download citation
DOI: https://doi.org/10.1007/978-88-470-2646-9_26
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2645-2
Online ISBN: 978-88-470-2646-9
eBook Packages: MedicineMedicine (R0)